Transaction · 0001491874-26-000005

Parker Geoffrey M.

Parker Geoffrey M., CFO, reported an open-market or private sale at Allogene Therapeutics, Inc. involving 36342.000000 shares for an estimated $48698.28. Reported holdings after the transaction were 1045877.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market sellSEC transaction code SCFO
ALLOAllogene Therapeutics, Inc.
Trade date
Oct 21, 2026
Filing date
Oct 23, 2026
View on SEC Insider profile
Estimated value-$48.6kShares × reported price
Shares traded36.3k$1.34 per share
Holdings after1.04MDirect
% of reported position traded3.36%This security and ownership context
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 1,082,219 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

ALLO price since this filing

Daily closing prices, with the filing date and available return windows
ALLO · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago1w ago1d ago
Returns since7d30d90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001491874-26-000005
Common Stock
Transaction date
Oct 21, 2026
Filed Oct 23, 2026, 08:48 PM · 2d delay
Shares
36,342 sh
$1.34 per share
Estimated value
-$48.6k
Computed from shares × price
Holdings after
1,045,877 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Direct Ownership
Filing-only score

+10 points

Compact filing score computed from stored Form 4 facts. Version v1.

Positive filing signal

This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • timely_filing+4 points

    reporting_delay_days = 2

    Filing reported within two business days of the transaction.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

CHIEF FINANCIAL OFFICER

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's electi…

  2. F2

    Reflects forfeiture of 195,000 shares subject to performance RSUs granted to the Reporting Person on October 10, 2023.

  3. F3

    Includes 12,500 shares of the Issuer's common stock acquired by the reporting person on March 15, 2026 pursuant to an employee stock purchase program.

  4. F4

    Includes 11,924 shares of the Issuer's common stock acquired by the reporting person on September 15, 2026 pursuant to an employee stock purchase program.

Original filing · 0001491874-26-000005
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

ALLO